The Institute for Medical Immunology works in close collaboration with BioWin. Located in Wallonia, The BioWin competitiveness cluster focuses its activities on the field of human health. Its ambition is to promote collaboration between all the Walloon stakeholders involved in innovation and training activities in the sector. Its objectives are:

 

The main stakeholders of the BioWin cluster BioWin is a network composed of approximately 250 Walloon actors coming from different horizons:

 

• More than 100 companies, including leading world companies such as GlaxoSmithKline Biologicals (vaccines), UCB (biopharmaceuticals), Baxter (medical devices) or IBA (cyclotrons and proton therapy) as well as a large number of high potential innovative SMEs.

• Seven Academic Institutions and Research Institutes from three Belgian Universities: the Université Libre de Bruxelles (ULB), the Université Catholique de Louvain (UCL) and the Université de Liège (ULg). 

• 23 research and training centres, including ARESA (a cluster of clinical research companies), Biovallée, Sirris, GIGA, and Cefochim.

• Several Institutes of higher education and a number of secondary technical schools
   
• Numerous Investors
   
• Institutional representatives

For more information on innovation themes, research projects, training activities, and detailed list of BioWin partners, please visit the BioWin Web site